effect of Lidocaine , esmolol and ketorolac in pain control when injecting rocuronium

Phase 3

• Conditions: pain during Rocuronium injection in general anesthesia induction.

• Registration Number: IRCT20220719055498N1
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 August 2022

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 176

Inclusion Criteria

Elective surgery candidates undergoing general anesthesia
ASA class I and II

Exclusion Criteria

History of Thrombophlebitis, vascular disease, chronic pain, Diabetes
History of burns, and tumors in the hand with the catheter
History of addiction or any contraindications for the drugs used in the study
Not consenting to participate in the study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Visual analog scale pain scores. Timepoint: during and 1 minute after Rocuronium injection. Method of measurement: visual analog scale pain.

Secondary Outcome Measures

Name	Time	Method
Mean arterial blood pressure. Timepoint: on entering the operation room, 5 minutes and ten minutes after injection of intervention drugs, at the time of induction and every 10 minutes after induction for 30 minutes. Method of measurement: Sphygmomanometer.;Arterial oxygen saturation. Timepoint: on entering the operation room, 5 minutes and ten minutes after injection of intervention drugs, at the time of induction and every 10 minutes after induction for 30 minutes. Method of measurement: pulse oximetry.;Heart beat. Timepoint: on entering the operation room, 5 minutes and ten minutes after injection of intervention drugs, at the time of induction and every 10 minutes after induction for 30 minutes. Method of measurement: taking Radial pulse for 1 minute.